PIK3CA and endometrial cancer: In endometrial cancer, genomic alterations are common in the phosphatidylinositol-3 kinase (PI3K) pathway (such as PTEN, PIK3CA, and PIK3R1) and the receptor tyrosine kinase/RAS pathway [4,5].